CHMFL-KIT-64
a novel c-KIT kinase inhibitor
Also Known As:
2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Bai, Mingfeng:
1 article
(11/2019)
|
2. | Cai, Yujiao:
1 article
(11/2019)
|
3. | Chen, Cheng:
1 article
(11/2019)
|
4. | Hu, Chen:
1 article
(11/2019)
|
5. | Hu, Zhenquan:
1 article
(11/2019)
|
6. | Liu, Feiyang:
1 article
(11/2019)
|
7. | Liu, Jing:
1 article
(11/2019)
|
8. | Liu, Qingsong:
1 article
(11/2019)
|
9. | Liu, Qingwang:
1 article
(11/2019)
|
10. | Qi, Shuang:
1 article
(11/2019)
|
Related Diseases
Related Drugs and Biologics